Starting late June, a groundbreaking blood test designed to diagnose Alzheimer’s disease will be available in the U.S., offering a faster and more cost-effective alternative to traditional methods. This innovation could revolutionize Alzheimer’s treatment and improve patient outcomes!
The FDA has approved the first blood test for Alzheimer's, allowing for earlier diagnosis and treatment with existing drugs. This groundbreaking development could significantly impact millions facing cognitive decline.
As organ shortages persist, scientists explore xenotransplantation — transplanting animal organs into humans. Discover the groundbreaking history and future potential of this life-saving innovation.
The FDA has approved a groundbreaking blood test, Lumipulse, that detects amyloid plaques linked to Alzheimer’s disease, offering a safer, more accessible diagnostic tool for millions.
The FDA has approved the Teal Wand, the first at-home alternative to Pap smears, offering a painless and convenient way for women to screen for cervical cancer. With the aim of increasing screening rates, this innovative device allows women to collect samples at home and mail them for lab testing.
In a surprising turn of events, Elizabeth Holmes' partner, Billy Evans, raises millions for an AI startup named Haemanthus, aimed at revolutionizing medical testing. As Holmes advises from prison, the venture seeks to make advanced diagnostic tools accessible to patients.
As AI enters hospitals, a new program called Ana is assisting patients around the clock. While some see it as a solution to nurse burnout, others fear it could undermine care quality. Explore the debate over AI's role in healthcare!
A groundbreaking daily pill for endometriosis has been approved for NHS use, allowing women to manage symptoms effectively at home. This first-of-its-kind treatment replaces multiple medications and clinic visits.
